Product safety and industry standards are a new trend in regulatory schemes for medical cannabis. This panel will discuss these trends including what is happening internationally and in the US.
Phillippe Lucas, M.A.
Amanda Reiman, Ph.D.
Marina Faz-Huppert is a resident of the City of Chicago. She has devoted her professional career to public service and advocating on behalf of working familes.
Currently, Faz-Huppert is the legislative and political director for Local 881 United Food and Commercial Workers International Union. The UFCW represents more than 34,000 members throughout Illinois and Northwest Indiana. She coordinates Local 881's political resources to assist candidates who support working families.
Jill’s background is in toll road operations and municipal bond finance; she received an MBA from the University of Denver in 1999. Jill has been a leader in Colorado’s medical marijuana industry since 2008 when she and her husband began one of the state’s most respected multi-location dispensary operations. She is a founding member of and served as the first woman Chairman of the National Cannabis Industry Association.
Mike Liszewski, J.D., is the Government Affairs Director at Americans for Safe Access. He spent his early career as a community organizer for Banner Neighborhoods in southeast Baltimore, MD, forming after-school reading, art, sports and employment programs for elementary and middle school-aged youth. As a law student, he helped lead a successful lobbying campaign that defeated an ill-conceived "gang injunction" bill, and clerked in DC Council Committee on Health as it was considering B18-622, the District's medical cannabis law. Mike served as a student member of SSDP's Board of Directors (2010-2012) and the ACLU-NCA (2010-2011). Shortly before joining ASA’s staff, he co-drafted the original version of what was eventually passed and signed into law in D.C. as the Good Samaritan Overdose Prevention Amendment Act of 2012.
Philippe Lucas MA is a Research Affiliate with the Center for Addictions Research of British Columbia and a founding Board member of the Multidisciplinary Association of Psychedelic Studies Canada and the Canadian Drug Policy Coalition.
Kristin Nevedal is the Director of the Patient Focused Certification Program. Before joining ASA she co-founded and served on the board of the Emerald Growers Association whose mission is to promote the medicinal, environmental, social, and economic benefits of lawfully cultivated sun-grown medical cannabis from California’s Emerald Triangle region by advocating for public policies that foster a healthy, sustainable medical cannabis industry.
Amanda Reiman is Manager of Marijuana Law and Policy at the Drug Policy Alliance, where she works to develop DPA’s marijuana reform work as it relates to litigation, legislative and initiative drafting, campaign strategy, policy advocacy, media relations, fundraising, and public education in the local, state, federal, and international jurisdictions in which DPA is active. Reiman joined DPA in 2012 after working with Berkeley Patients Group, a renowned medical marijuana dispensary, as director of research and patient services.